News

Novocardia™ Named Among New York City’s Top 101 Health Care Companies and Startups of 2021

Company Recognized for Leading Innovation in Cardiovascular Disease Care with Value-Based Care Delivery Platform
SUBSCRIBE TO
NEWS & INSIGHTS

    NEW YORK, Nov. 4, 2021— Novocardia, a value-based cardiovascular disease care delivery platform, today announced that it has been named one of the ‘101 Top New York City Health Care Companies and Startups of 2021′ by BestStartup.us.

    The BestStartup.us list features NYC-based health care companies and startups chosen by industry professionals for exceptional performance in innovation, growth, management, and societal impact. From cutting-edge startups to established brands, Novocardia joins the ranks of companies like Peloton, Cedar, Spring Health, LetsGetChecked, Oscar Health, Spring Health and Zocdoc, bringing innovative ideas and products to market, delivering exceptional growth, and addressing important societal challenges.

    “Novocardia is honored to be named one of the top health care companies in New York City by BestStartup.us, as we work to transform how cardiovascular disease care is delivered in the United States,” said Daniel Blumenthal, MD, MBA, Chief Executive Officer of Novocardia.

    “Cardiovascular disease is the single largest driver of health care spending in the United States, and accounts for approximately $320 billion in direct medical spending each year. We are focused on helping cardiologists to provide better care at lower cost and improving access to high quality cardiovascular disease care.”*

    Founded in 2020 by two cardiologists – Dr. Dan Blumenthal and Dr. Julius Torelli, FACC – Novocardia is committed to building a network of leading cardiologists and investing in their practices so that they can grow and adapt to changes in the health care landscape, including the shift to fee-for-value reimbursement models. Novocardia is focused on improving patient quality and outcomes through proactive and prevention-focused care, a proprietary actuarial and quality-focused analytics platform, and aligned partnerships with health plans and referral partners.

    “As Novocardia continues to expand in 2022, the key to our success remains the same – putting cardiologists, and their patients, at the center of care,” said Dr. Torelli, Novocardia’s Chief Medical Officer. “We invest in and partner with cardiologists in an increasingly complex care delivery and payment environment. With our support, cardiologists can succeed at delivering high-quality, high-value care that benefits patients, as well as health plans, primary care groups, and other referral sources.”

    ABOUT NOVOCARDIA™

    Founded in 2020, Novocardia is on a mission to transform how cardiovascular disease care is delivered in the United States and help patients with heart and vascular disease live longer, healthier, and more satisfying lives. Novocardia is committed to putting cardiologists, and their patients, at the center of care by investing in our partner practices, deploying purpose-built data and analytics tools to improve patient outcomes, and enabling our partners to transition more successfully to value-based care. To learn more about Novocardia, please visit www.novocardiahealth.com.

    ABOUT BESTSTARTUP.US

    Annually, BestStartup.us awards the most successful startups in the U.S. with its lists featuring companies who are pushing the limits of innovation to solve critical problems and challenges. Created by Fupping LTD, a London-based media company, the mission of BestStartUp.us is to promote the greatest American companies, businesses and innovations on the global stage boosting inbound investment by addressing the information asymmetry between small innovative startups and institutional investors.

     

    * Sources: United States Centers for Disease Control. Available at: https://www.cdc.gov/chronicdisease/about/costs/index.htm and www.cdcfoundation.org/pr/2015/heart-disease-and-stroke-cost-america-nearly-1-billion-day-medical-costs-lost-productivity

    Novocardia™ Recognized as a Rising
    Disruptor by Bernstein in U.S. Health
    Care Services

    Novocardia Joins List of Fast-Growing Private Companies Transforming Health Care Delivery & Outcomes
    Read
    More

    Novocardia™ Enters Into
    Partnership with MedAxiom™

    Strategic Alliance Focused on Promoting Common Mission of Transforming Quality, Value, and Outcomes of Cardiovascular Care
    Read
    More

    Novocardia™ Announces
    Key Additions to Leadership Team
    Accelerating Company’s Mission
    & Growth

    Executives Bring Decades of Multifaceted Health Care Experience that Will Enable Cardiologists to More Successfully Navigate Shifts in Cardiovascular Disease Care
    Read
    More

    Novocardia™ Announces
    Partnership with First Coast Heart
    & Vascular Center

    Alliance to Focus on Improving the Quality, Access, and Value
    of Cardiovascular Disease Care in Northeast Florida
    Read
    More

    Novocardia™ Announces
    $53.7 Million Financing Led
    by Deerfield Management

    New Venture to Partner with Cardiologists to Improve the Quality
    and Value of Cardiovascular Care in the United States
    Read
    More
    Contact Us
    345 Park Avenue South, 12th Floor
    New York, NY 10010
    Get Novocardia news, events, and innovations delivered right to your inbox.